Similar recurrence after curative treatment of HBV-related HCC, regardless of HBV replication activity.

ABSTRACT:

Background and aims

Antiviral therapy (AVT) is required in patients with newly diagnosed hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC), if HBV DNA is detectable. We compared the risk of recurrence according to HBV replication activity at the curative treatment of HBV-related HCC.

Methods

Patients with HBV-related HCC who underwent surgical resection or radiofrequency ablation between 2013 and 2018 were enrolled in this retrospective cohort study. Patients were categorized into two groups according to HBV replication activity at the curative treatment of HBV-related HCC (group 1: patients who met the AVT indication for HBV-related HCC due to detectable HBV DNA but did not meet the AVT indication if without HCC; group 2: patients who met the AVT indication, re

SUBMITTER: Kim MN 

PROVIDER: S-EPMC11346930 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature